tiprankstipranks
Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
:6826
Hong Kong Market
6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
RESEARCH TOOLSreports

Shanghai Haohai Biological Technology Co., Ltd. Class H (6826) Ratios

1 Followers

Shanghai Haohai Biological Technology Co., Ltd. Class H Ratios

HK:6826's free cash flow for Q4 2025 was ¥0.65. For the 2025 fiscal year, HK:6826's free cash flow was decreased by ¥ and operating cash flow was ¥-0.28. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.79 3.79 4.22 5.24 6.91
Quick Ratio
 3.21 3.21 3.66 4.50 5.96
Cash Ratio
 2.68 2.68 3.04 3.83 4.97
Solvency Ratio
 0.38 0.40 0.50 0.56 0.39
Operating Cash Flow Ratio
 0.70 0.69 0.75 0.89 0.45
Short-Term Operating Cash Flow Coverage
 1.92 1.88 2.26 3.23 17.77
Net Current Asset Value
¥ 2.35B¥ 2.35B¥ 2.45B¥ 2.66B¥ 2.54B
Leverage Ratios
Debt-to-Assets Ratio
 0.06 0.06 0.06 0.06 0.02
Debt-to-Equity Ratio
 0.07 0.07 0.08 0.07 0.02
Debt-to-Capital Ratio
 0.07 0.07 0.07 0.07 0.02
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.02 0.03 <0.01
Financial Leverage Ratio
 1.24 1.24 1.28 1.26 1.25
Debt Service Coverage Ratio
 1.21 1.28 1.50 3.03 19.50
Interest Coverage Ratio
 11.68 15.17 19.26 60.09 20.49
Debt to Market Cap
 0.05 0.07 0.07 0.08 0.01
Interest Debt Per Share
 1.80 1.79 2.00 2.43 0.73
Net Debt to EBITDA
 -4.92 -4.27 -3.97 -3.27 -5.41
Profitability Margins
Gross Profit Margin
100.00%65.14%69.74%70.34%68.79%
EBIT Margin
9.69%11.64%13.88%19.57%11.57%
EBITDA Margin
16.84%20.04%20.49%27.08%21.28%
Operating Profit Margin
8.92%11.64%12.98%16.64%7.41%
Pretax Profit Margin
9.69%9.74%17.40%19.29%11.21%
Net Profit Margin
10.15%10.20%15.69%15.79%8.58%
Continuous Operations Profit Margin
10.15%8.47%14.04%15.65%9.05%
Net Income Per EBT
104.79%104.79%90.20%81.87%76.56%
EBT Per EBIT
108.63%83.64%133.98%115.94%151.29%
Return on Assets (ROA)
3.74%3.64%5.90%5.86%2.62%
Return on Equity (ROE)
4.50%4.51%7.54%7.36%3.27%
Return on Capital Employed (ROCE)
3.80%4.80%5.56%6.86%2.44%
Return on Invested Capital (ROIC)
3.59%3.96%4.28%5.38%1.96%
Return on Tangible Assets
4.15%4.04%7.02%6.98%3.17%
Earnings Yield
2.70%4.80%7.21%9.90%4.47%
Efficiency Ratios
Receivables Turnover
 8.98 8.70 7.26 7.82 5.42
Payables Turnover
 16.50 12.26 13.06 14.18 12.04
Inventory Turnover
 2.15 1.60 1.65 1.49 1.35
Fixed Asset Turnover
 1.29 1.25 1.51 1.70 1.49
Asset Turnover
 0.37 0.36 0.38 0.37 0.31
Working Capital Turnover Ratio
 0.95 0.90 0.92 0.87 0.67
Cash Conversion Cycle
 188.23 240.71 243.21 266.73 306.83
Days of Sales Outstanding
 40.66 41.97 50.31 46.69 67.38
Days of Inventory Outstanding
 169.69 228.53 220.86 245.78 269.78
Days of Payables Outstanding
 22.11 29.78 27.95 25.74 30.32
Operating Cycle
 210.34 270.49 271.16 292.48 337.15
Cash Flow Ratios
Operating Cash Flow Per Share
 2.77 2.70 2.78 3.72 1.33
Free Cash Flow Per Share
 1.97 1.92 1.21 2.15 -0.49
CapEx Per Share
 0.81 0.78 1.57 1.56 1.83
Free Cash Flow to Operating Cash Flow
 0.71 0.71 0.44 0.58 -0.37
Dividend Paid and CapEx Coverage Ratio
 1.29 1.55 1.04 1.86 0.53
Capital Expenditure Coverage Ratio
 3.44 3.45 1.77 2.37 0.73
Operating Cash Flow Coverage Ratio
 1.61 1.58 1.45 1.56 1.96
Operating Cash Flow to Sales Ratio
 0.26 0.26 0.24 0.24 0.11
Free Cash Flow Yield
5.98%8.76%4.85%8.73%-2.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 36.04 20.83 13.88 10.11 22.35
Price-to-Sales (P/S) Ratio
 3.00 2.13 2.18 1.60 1.92
Price-to-Book (P/B) Ratio
 1.67 0.94 1.05 0.74 0.73
Price-to-Free Cash Flow (P/FCF) Ratio
 16.25 11.41 20.61 11.45 -46.98
Price-to-Operating Cash Flow Ratio
 14.06 8.10 9.00 6.63 17.44
Price-to-Earnings Growth (PEG) Ratio
 -1.04 -0.50 -0.53 0.08 -0.47
Price-to-Fair Value
 1.67 0.94 1.05 0.74 0.73
Enterprise Value Multiple
 12.89 6.34 6.65 2.63 3.60
Enterprise Value
 5.58B 3.04B 3.65B 1.87B 1.61B
EV to EBITDA
 13.39 6.34 6.65 2.63 3.60
EV to Sales
 2.26 1.27 1.36 0.71 0.77
EV to Free Cash Flow
 12.22 6.82 12.91 5.10 -18.75
EV to Operating Cash Flow
 8.67 4.84 5.63 2.95 6.96
Tangible Book Value Per Share
 21.25 21.22 20.54 28.55 27.13
Shareholders’ Equity Per Share
 23.37 23.34 23.92 33.09 31.78
Tax and Other Ratios
Effective Tax Rate
 -0.05 0.13 0.19 0.19 0.19
Revenue Per Share
 10.66 10.31 11.50 15.43 12.12
Net Income Per Share
 1.08 1.05 1.80 2.44 1.04
Tax Burden
 1.05 1.05 0.90 0.82 0.77
Interest Burden
 1.00 0.84 1.25 0.99 0.97
Research & Development to Revenue
 0.12 0.00 0.10 0.08 0.09
SG&A to Revenue
 0.75 0.00 0.46 0.16 0.19
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 <0.01 0.01
Income Quality
 2.56 2.57 1.39 1.25 0.98
Currency in CNY